RNA Therapeutics Part A

RNA Therapeutics, Part A, Volume 203, covers the latest developments in RNA molecules as a new class of medication, including their potential applications, molecular mechanisms, and clinical applications.

Format: Hardback
Length: 300 pages
Publication date: 15 February 2024
Publisher: Elsevier Science Publishing Co Inc

The groundbreaking field of RNA therapeutics is explored in depth in RNA Therapeutics, Part A, Volume 203. This comprehensive volume presents the latest advancements in a novel class of medications based on RNA molecules. The book offers timely chapters that delve into various aspects of RNA therapeutics, including an introduction to this emerging field and its potential applications.

The development and technologies of RNA therapeutics are extensively covered, providing insights into the techniques and tools used to create and deliver RNA-based therapies. The book explores different types of RNA therapeutics, such as small interfering RNAs (siRNAs) and messenger RNA (mRNA) vaccines, and discusses their molecular mechanisms of action.

Furthermore, the book explores the exciting applications of IT and AI in RNA therapeutics, including data science and bioinformatics, which play a crucial role in understanding RNA structure, function, and drug discovery. The application of these technologies in RNA therapeutics is discussed in detail, highlighting their potential to improve therapeutic outcomes and accelerate drug development processes.

The history and future perspectives of RNA therapeutics are also explored, providing a comprehensive understanding of the field's evolution and the challenges that lie ahead. Recent applications of RNA therapeutic in clinics are discussed, showcasing their success in treating various diseases, including neurological disorders, metabolic disorders, and cancer.

Advantages and disadvantages of RNA therapeutics are examined, highlighting the potential benefits and risks associated with RNA-based therapies. The book also explores the specific applications of RNA therapeutics in neurological diseases, metabolic disorders, and cancer, providing a comprehensive overview of this rapidly evolving field.

In conclusion, RNA Therapeutics, Part A, Volume 203 is a vital resource for researchers, clinicians, and healthcare professionals interested in the field of RNA therapeutics. The book offers a comprehensive and up-to-date overview of this emerging field, covering key topics such as RNA therapeutics introduction, development, technologies, types, molecular mechanisms, IT and AI applications, data sciences and bioinformatics, history and future perspectives, recent applications in clinics, advantages and disadvantages, and specific applications in neurological disease, metabolic disorder, and cancer.

Weight: 652g
Dimension: 159 x 239 x 24 (mm)
ISBN-13: 9780443223143